Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries AbbVie (NY: ABBV ) 191.03 -0.23 (-0.12%) Streaming Delayed Price Updated: 3:03 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 3,467,171 Open 190.10 Bid (Size) 190.99 (1) Ask (Size) 191.05 (4) Prev. Close 191.26 Today's Range 189.62 - 192.87 52wk Range 135.85 - 199.95 Shares Outstanding N/A Dividend Yield 3.10% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease Today 11:14 EDT AbbVie reports positive Phase 3 results for tavapadon, a once-daily treatment for early-stage Parkinson's disease. The drug showed significant improvements in patient symptoms, meeting primary and... Via Benzinga Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead Today 8:30 EDT Even the mighty Novo Nordisk can't hold a candle to its peer in this area. Via The Motley Fool Performance YTD +19.53% +19.53% 1 Month -3.25% -3.25% 3 Month +11.62% +11.62% 6 Month +5.92% +5.92% 1 Year +24.12% +24.12% More News Read More Behind the Scenes of AbbVie's Latest Options Trends September 24, 2024 Via Benzinga Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years September 20, 2024 Via Benzinga Exposures Product Safety Spotlight on AbbVie: Analyzing the Surge in Options Activity September 20, 2024 Via Benzinga Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry September 19, 2024 Via Benzinga Is ABBVIE INC Ready to Break Out of Its Range? September 17, 2024 Via Chartmill What the Options Market Tells Us About AbbVie September 11, 2024 Via Benzinga Spotlight on AbbVie: Analyzing the Surge in Options Activity September 09, 2024 Via Benzinga Peering Into AbbVie's Recent Short Interest September 06, 2024 Via Benzinga 2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure? September 19, 2024 Via Investor's Business Daily 2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again September 19, 2024 Via The Motley Fool Topics Stocks Exposures US Equities Abbie Inc Stocks Elliott Wave Technical Analysis - Wednesday, September 18, September 18, 2024 Via Talk Markets TransDigm, BJ's Wholesale, AbbVie And More On CNBC's 'Final Trades' September 17, 2024 Via Benzinga Topics ETFs Can AbbVie Regain Its Status As a Top Dividend Growth Stock? September 16, 2024 Via The Motley Fool Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More September 14, 2024 Via The Motley Fool 3 Stocks to Buy and Hold Forever September 14, 2024 Via The Motley Fool Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever September 14, 2024 Via The Motley Fool Time To Invest And Or Trade In Bio-Tech Stocks? September 13, 2024 Via Talk Markets Topics ETFs Is This Company Still a Strong Buy After Tripling the S&P 500's Returns? September 13, 2024 Via The Motley Fool Topics Stocks Exposures US Equities UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars September 11, 2024 Via Benzinga Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies September 10, 2024 Via Benzinga 3 Things You Need to Know if You Buy AbbVie Stock Today September 09, 2024 Via The Motley Fool 3 No-Brainer Dividend Stocks to Buy in September September 08, 2024 Via The Motley Fool Earn $1,000 Per Month in Dividends From These 4 Stocks September 07, 2024 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
